What is CBD (Cannabidiol)?
Cannabidiol (CBD) is by far the most studied natural cannabinoid. Thousands of peer-reviewed studies indicate that CBD possesses almost unbelievable clinical potential. CBD stands for cannabidiol, the most prominent naturally-occurring cannabinoid component found in cannabis that comprises up to 40% of the plant. After THC (Δ9-tetrahydrocannabinol), CBD is by far the most studied natural cannabinoid and is the cannabinoid that possesses the greatest therapeutic potential. According to many scientists, physicians and researchers, CBD may be the single most important cannabinoid ever discovered. Cannabidiol was first isolated in the 1930s and 1940s. Its structure and configuration were fully described in the 1960s by Professor Raphael Mechoulam and his team of researchers in Israel. As of 2013, PubMed.gov—a service of the National Institutes of Health—has indexed over 1,100 studies on cannabidiol. Cannabidiol is “a cannabinoid devoid of psychoactive effect,” and may have broad clinical potential for an astonishing spectrum of ailments.
Cannabinoids and the Endocannabinoid system.
One hefty word that belongs in every CBD believers vocabulary is cannabinoid. Cannabinoids (CBD) is the chemical compounds inside the Hemp plant that have been reported to provide relief to an array of ailments. These (Cannabinoids) work their magic by imitating compounds our bodies naturally produce, called endocannabinoids, which activate to maintain internal stability and health.
To put a complex system simply, they mediate communication between cells, and when there is a deficiency or problem with our endocannabinoid system, unpleasant symptoms and physical complications can occur. When CBD is consumed, cannabinoids bind to receptor sites throughout our brain and body. Different cannabinoids have different effects depending on which receptors they bind to.
This concept is the cornerstone of CBD therapy, and the results are so promising that these cannabinoids have been synthesized for legal prescription use. Some synthetic cannabinoid medications include Marinol, Nabilone, Sativex, and Rimonabant. While these synthetic forms are effective, research shows that herbal CBD can contains a far wider variety of therapeutic compounds and the Hemp plant contains at least 85 types of cannabinoids, many of which have shown great value.
CBD’s time is here!
For decades, cannabis activists and growers were focused on cultivating high-THC strains of cannabis, and struggled to convince the world of its medicinal benefits. The medical cannabis movement continues to tout the therapeutic properties of THC, but is facing a critical sea change as research continues to reveal the immense health benefits of CBD—without a need for the “high” from THC at all. In fact, there have been more scientific studies on CBD in the last decade than in the years since its discovery.
The results of this research have been so promising for so many ailments that it might be non-psychoactive, non-addictive CBD that finally brings cannabis prohibition to an end. As the push for cannabis legalization continues, the demand for access to CBD for research, clinical trials, and drug development will only increase. Hundreds of scientists from pharmaceutical companies—including GW pharma, Merck, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, and Allergan—are already regularly attending meetings of the International Cannabinoid Research Society. The question is, will the rest of the world be ready?